Search Results 1881-1890 of 16944 for Celecoxib
Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible predictors for mild cognitive impairment and dementia. A Study of ...
Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, ...
Cardiovascular. Mayo Clinic Discovery Leads to FDA Approval for Stem Cell Trial for Heart Failure Patients. Dennis Douda. January 17, 2014 ; Cancer. Discovery's ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data ...
Mayo Clinic Proceedings published a series of 10 thematic reviews that look at how clinical trials are changing, led by digitalization and decentralization.
Learn about the expertise and advanced diagnostic and treatment services for people with complex or serious conditions of the heart and blood vessels.
Amir Lerman, M.D., a cardiovascular physician-scientist, mentor, research leader and active Mayo Clinic staff member, passed away Feb. 23 at age 69. During his ...
About this study. The goal of the study is to identify and validate flow measurement and ultrasound images in patients undergoing vein bypass surgery ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!